Grufity logo
Grufity logo

Latest Vestal Point Capital, LP Stock Portfolio

$4.28Billion | No. of Holdings #68

Vestal Point Capital, LP Performance

2026 Q2+12.97%
YTD+14.05%
2025+15.37%

About Vestal Point Capital, LP and 13F Hedge Fund Stock Holdings

Vestal Point Capital, LP is a hedge fund based in New York, NY. On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Vestal Point Capital, LP reported an equity portfolio of $4.3 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of Vestal Point Capital, LP are BMRN, NBIX, . The fund has invested 8.1% of it's portfolio in BIOMARIN PHARMACEUTICAL INC and 7.4% of portfolio in NEUROCRINE BIOSCIENCES INC. <br><br> The fund managers got completely rid off APOGEE THERAPEUTICS INC, ASCENDIS PHARMA A/S (ASND) and SCHOLAR ROCK HOLDING CORP (SRRK) stocks. They significantly reduced their stock positions in REVOLUTION MEDICINES INC (RVMD), ALTO NEUROSCIENCE INC and SOLID BIOSCIENCES INC (SLDB). Vestal Point Capital, LP opened new stock positions in ABBOTT LABORATORIES (ABT), ASCENDIS PHARMA A/S and INSMED INC (INSM). The fund showed a lot of confidence in some stocks as they added substantially to INSULET CORP (PODD), ZIMMER BIOMET HOLDINGS INC (ZBH) and UNITED THERAPEUTICS CORP (UTHR).
Vestal Point Capital, LP Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$4.28Billion
  as of Aug 14, 2026

Vestal Point Capital, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Vestal Point Capital, LP made a return of 12.97% in the last quarter. In trailing 12 months, it's portfolio return was 54.87%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
abbott laboratories127,036,000
ascendis pharma a/s100,020,000
insmed inc26,655,000
first tracks biotherapeutics i20,381,600
avalo therapeutics inc14,322,000
evommune inc13,290,000
kailera therapeutics inc12,667,200
ibio inc4,550,000
New stocks bought by Vestal Point Capital, LP

Additions

Ticker% Inc.
insulet corp1,224
zimmer biomet holdings inc636
united therapeutics corp480
tarsus pharmaceuticals inc425
astrazeneca plc350
nektar therapeutics250
myriad genetics inc248
uniqure nv160
Additions to existing portfolio by Vestal Point Capital, LP

Reductions

Ticker% Reduced
revolution medicines inc-81.05
alto neuroscience inc-61.97
solid biosciences inc-56.8
repligen corp-56.76
rapport therapeutics inc-49.17
alcon ag-37.5
immunocore holdings plc-34.94
arrowhead pharmaceuticals inc-30.77
Vestal Point Capital, LP reduced stake in above stock

Sold off

Ticker$ Sold
geron corp-3,784,600
engene therapeutics inc-14,743,600
kalvista pharmaceuticals inc-37,240,500
denali therapeutics inc-34,047,900
vera therapeutics inc-55,041,000
scholar rock holding corp-65,108,600
cogent biosciences inc-47,376,900
celldex therapeutics inc-38,830,500
Vestal Point Capital, LP got rid off the above stocks

Sector Distribution

Vestal Point Capital, LP has about 64.5% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare64.5
Others35.5

Market Cap. Distribution

Vestal Point Capital, LP has about 38.8% of it's portfolio invested in the large-cap and mega-cap stocks.

  • LARGE-CAP
  • UNALLOCATED
  • MID-CAP
  • SMALL-CAP
Category%
LARGE-CAP38.8
UNALLOCATED35.5
MID-CAP16.7
SMALL-CAP8.5

Stocks belong to which Index?

About 32.1% of the stocks held by Vestal Point Capital, LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
  • S&P 500
Index%
Others67.9
RUSSELL 200022.3
S&P 5009.8
Top 5 Winners (%)%
QURE
uniqure nv
80.6 %
anteris technologies global co
72.9 %
MNPR
monopar therapeutics inc
61.4 %
RVMD
revolution medicines inc
55.1 %
TSHA
taysha gene therapies inc
49.5 %
Top 5 Winners ($)$
RVMD
revolution medicines inc
127.2 M
NRIX
nurix therapeutics inc
63.7 M
NBIX
neurocrine biosciences inc
57.6 M
bicara therapeutics inc
52.3 M
TSHA
taysha gene therapies inc
43.8 M
Top 5 Losers (%)%
nyxoah sa
-41.5 %
REGN
regeneron pharmaceuticals inc
-19.3 %
lexeo therapeutics inc
-18.6 %
PODD
insulet corp
-16.9 %
OLMA
olema pharmaceuticals inc
-15.9 %
Top 5 Losers ($)$
PODD
insulet corp
-20.7 M
UTHR
united therapeutics corp
-13.0 M
SNY
sanofi sa
-9.4 M
REGN
regeneron pharmaceuticals inc
-6.0 M
ALC
alcon ag
-5.4 M

Vestal Point Capital, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Vestal Point Capital, LP

Vestal Point Capital, LP has 68 stocks in it's portfolio. About 50.3% of the portfolio is in top 10 stocks. PODD proved to be the most loss making stock for the portfolio. RVMD was the most profitable stock for Vestal Point Capital, LP last quarter.

$4.28BTotal Value
101Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Vestal Point Capital, LP, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ALC
Alcon Ag

Alcon Ag

ALC
Vestal Point Capital, LP's holding in Alcon Ag over time
0.78%500,000
$33.55M
0.78%
decreased 37.5 percentreduced
ASND
Ascendis Pharma A/S

Ascendis Pharma A/S

ASND
Vestal Point Capital, LP's holding in Ascendis Pharma A/S over time
0%0.00
$0.00
0%
decreased 100 percentsold off
DRUG
Bright Minds Biosciences Inc

Bright Minds Biosciences Inc

DRUG
Vestal Point Capital, LP's holding in Bright Minds Biosciences Inc over time
0.89%545,000
$38.26M
0.89%
increased 10.7 percentadded